-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Last year, the world conducted in-depth research on SARS-CoV-2 ( the virus that caused the COVID-19 pandemic).
COVID-19 infection
HIV, Ebola virus and now SARS-CoV-2 are all RNA viruses, and these viruses have caused many health disasters.
management
Haruhisa Inoue said: "Not only is it necessary to treat current RNA viruses, but also emerging anti-RNA viral therapies.
prevention
Sendai virus is an RNA virus commonly used in iPS cell research.
From the screening of 500 drugs, 5 showed promising prospects worthy of further research, including raloxifene (a drug used to treat breast cancer and osteoporosis ) and pioglitazone (a drug used to treat diabetes medicine).
From the screening of 500 drugs, 5 showed promising prospects worthy of further research, including raloxifene (a drug used to treat breast cancer and osteoporosis ) and pioglitazone (a drug used to treat diabetes medicine).
Original source:
Original source:href="" target="_blank" rel="noopener">